Target: Ian Read, President & CEO of Pfizer, Inc.
Goal: Support healthier lifestyles by funding alternative weight loss research
Recently, David Ludwig and Mark Friedman of the New York Times published an article titled “Always Hungry? Here’s Why,” presenting an opposing view to the widely accepted cultural assumption that counting calories is how one can lose the most weight. To a certain extent, this old assumption makes sense: eat less than you burn, and your waist size will shrink. So then why are obesity rates higher than they have ever been before, especially when the focus on nutrition has never been higher in America?
What Ludwig and Friedman propose is that it may not be our lack of willpower that is contributing to the spread of the “epidemic” that is obesity. A recent study published by the Journal of the American Medical Association (JAMA) showed that environmental causes directly correlate with our modern bodies’ desires for calorie-rich foods.
So what does that mean? It means that simply slashing calories will not be the long term fix. Studies have shown that only 1 in 6 overweight adults could maintain a 10% weight loss for longer than a year.
With this evidence out there, Ludwig and Friedman encouraged the sponsoring of clinical trials that would explore this theory in more depth. However, they conveniently left out who the sponsors should be. Pfizer is one of the biggest pharmaceutical companies out there, only running second to Johnson and Johnson. Pfizer has the money to invest in these clinical trials, and since most of their drugs (Lipitor for high cholesterol, Exubera for diabetes, etc.) alleviate symptoms often linked to obesity, they should be held responsible for investing in a cure. Sign the petition below to demand that Pfizer take responsibility.
Dear Ian Read,
As I am sure you are well aware, obesity is one of the fastest growing epidemics in this country as well as worldwide. For years, measures have been taken to slow this trend, but nothing is working. It is time to walk down a new path and we are asking your corporation to be the leader in investing in clinical trials that will test alternative theories to cutting calories that may result in people being able to become healthy long term.
We understand that your company benefits from having obese people. Without obese people, who would take Accupril for hypertension (a common side effect of obesity) or Lipitor for high cholesterol? However, we encourage you to be a pioneer in creating new and more beneficial ways to gain profit for your corporation. Besides the fact that you could potentially be investing in clinical trials that would improve the lives of millions of people, imagine the notoriety and appreciation Pfizer would get if it could be the one to tell people that they do not constantly have to think about how many calories they are consuming.
Please help us end the calorie counting madness.
[Your Name Here]
Photo credit: slowburnfitness.com